Daniel Byczkowski

Statistics

Publications

Citations

H-Index

Active since

2017

Affiliations

Prolong Pharmaceuticals (United States)(Current)

Daniel Byczkowski is an author at Prolong Pharmaceuticals (United States) specializing in kidney transplantation, non-st-elevation myocardial infarction, and pharmacokinetic biomarkers in transplantation.

Publications per year

2017–2017

Publications

A phase Ib, open‐label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of <scp>SANGUINATE</scp> infusion in patients with end‐stage renal disease

Bassam G. Abu Jawdeh, E. Steve Woodle, Abbie D. Leino et al. · Clinical Transplantation · 2017 · 18 citations

Medicine, Pharmacokinetics, Pharmacology +16

1–1 of 1